• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估多发性硬化症残疾状况的性能量表的有效性。

Validity of performance scales for disability assessment in multiple sclerosis.

作者信息

Marrie R A, Goldman M

机构信息

Department of Neurology, Cleveland Clinic, Cleveland, OH, USA.

出版信息

Mult Scler. 2007 Nov;13(9):1176-82. doi: 10.1177/1352458507078388. Epub 2007 Jul 10.

DOI:10.1177/1352458507078388
PMID:17623733
Abstract

Researchers increasingly use self-reported health status assessments, but these require validation. Performance Scales (PS) is a self-report measure for multiple sclerosis (MS)-associated disability, assessing mobility, bowel/bladder, fatigue, sensory, vision, cognition, spasticity and hand function. The criterion validity of the total PS score was established using the Expanded Disability Status Scale (EDSS), but the construct and criterion validity of the individual subscales have not been established. We assessed the criterion and construct validity of the PS subscales. Forty-four patients with MS completed PS, and these criterion measurements: neurological examination (EDSS), the Multiple Sclerosis Functional Composite (MSFC), contrast acuity testing, and the Multiple Sclerosis Quality of Life Inventory. We assessed criterion and construct validity with Spearman rank correlations between PS subscales and the other measurements. PS correlated with the MSFC (r=-0.58, P<0.0001). The mobility, hand, vision, fatigue and bladder subscales correlated with their criterion measures (r=0.59-0.77, P<0.0001). The sensory subscale correlated weakly with the sensory functional system score (r=0.39, P=0.01 ), and the cognitive subscale did not correlate with the PASAT (r=-0.17, P=0.26). This study supports the criterion and construct validity of PS overall, and its mobility, hand, vision, fatigue, and bladder subscales. Further assessment of the cognitive, sensory and spasticity subscales is needed.

摘要

研究人员越来越多地使用自我报告的健康状况评估方法,但这些方法需要进行验证。性能量表(PS)是一种用于评估与多发性硬化症(MS)相关残疾的自我报告测量工具,可评估运动能力、肠道/膀胱功能、疲劳、感觉、视力、认知、痉挛状态和手部功能。PS总分的效标效度已通过扩展残疾状态量表(EDSS)得以确立,但各个子量表的结构效度和效标效度尚未确立。我们评估了PS子量表的效标效度和结构效度。44例MS患者完成了PS量表以及以下效标测量:神经学检查(EDSS)、多发性硬化症功能综合量表(MSFC)、对比敏感度测试以及多发性硬化症生活质量量表。我们通过PS子量表与其他测量指标之间的Spearman等级相关性来评估效标效度和结构效度。PS与MSFC相关(r = -0.58,P < 0.0001)。运动能力、手部、视力、疲劳和膀胱功能子量表与其效标测量指标相关(r = 0.59 - 0.77,P < 0.0001)。感觉功能子量表与感觉功能系统评分的相关性较弱(r = 0.39,P = 0.01),认知子量表与PASAT不相关(r = -0.17,P = 0.26)。本研究支持PS量表整体及其运动能力、手部、视力、疲劳和膀胱功能子量表的效标效度和结构效度。需要对认知、感觉和痉挛状态子量表进行进一步评估。

相似文献

1
Validity of performance scales for disability assessment in multiple sclerosis.用于评估多发性硬化症残疾状况的性能量表的有效性。
Mult Scler. 2007 Nov;13(9):1176-82. doi: 10.1177/1352458507078388. Epub 2007 Jul 10.
2
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.低对比度字母视力测试可发现多发性硬化症患者的视觉功能障碍。
Neurology. 2005 Mar 22;64(6):992-5. doi: 10.1212/01.WNL.0000154521.40686.63.
3
[Sleepiness and fatigue in multiple sclerosis - comparison of different measuring instruments].[多发性硬化症中的嗜睡与疲劳——不同测量工具的比较]
Fortschr Neurol Psychiatr. 2003 Nov;71(11):590-4. doi: 10.1055/s-2003-43464.
4
Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.多发性硬化症患者复发治疗期间及之后,多发性硬化功能综合评分、扩展残疾状态量表与健康相关生活质量之间的相关性。
J Neurol Sci. 2004 Mar 15;218(1-2):3-7. doi: 10.1016/j.jns.2003.09.015.
5
Disparities in the management of multiple sclerosis-related bladder symptoms.多发性硬化症相关膀胱症状管理方面的差异。
Neurology. 2007 Jun 5;68(23):1971-8. doi: 10.1212/01.wnl.0000264416.53077.8b.
6
Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.多发性硬化症功能综合量表的心理测量学和常模数据:用符号数字模态测试替代 PASAT。
Mult Scler. 2010 Feb;16(2):228-37. doi: 10.1177/1352458509354552. Epub 2009 Dec 22.
7
Cognitive fatigue in multiple sclerosis: findings from a two-wave screening project.多发性硬化症中的认知疲劳:一项两阶段筛查项目的研究结果
J Neurol Sci. 2006 Jun 15;245(1-2):73-6. doi: 10.1016/j.jns.2005.09.015. Epub 2006 Apr 19.
8
[Application of the Multiple Sclerosis Functional Composite in Debrecen].[多发性硬化功能综合评分在德布勒森的应用]
Ideggyogy Sz. 2005 Mar 20;58(3-4):113-8.
9
Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients.多发性硬化症患者上肢功能的运动评估及其与疲劳、认知功能和生活质量的关系。
J Neurol Sci. 2006 Jul 15;246(1-2):117-22. doi: 10.1016/j.jns.2006.02.018. Epub 2006 May 5.
10
Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.评估系统性硬化症患者的残疾情况和生活质量:科钦手功能量表、健康评估问卷(HAQ)、系统性硬化症HAQ及医学结局研究36项简短健康调查的结构效度。
Arthritis Rheum. 2007 Feb 15;57(1):94-102. doi: 10.1002/art.22468.

引用本文的文献

1
Infection, Relapses, and Pseudo-Relapses in Individuals With Multiple Sclerosis.多发性硬化症患者的感染、复发及假性复发
Neurol Clin Pract. 2025 Aug;15(4):e200493. doi: 10.1212/CPJ.0000000000200493. Epub 2025 Jun 4.
2
Assessing fall risk in multiple sclerosis using patient-reported outcomes and wearable gait metrics.使用患者报告结局和可穿戴步态指标评估多发性硬化症患者的跌倒风险。
Mult Scler J Exp Transl Clin. 2025 Apr 16;11(2):20552173251329825. doi: 10.1177/20552173251329825. eCollection 2025 Apr-Jun.
3
Psychosocial Factors are Associated With Walking-Related Goal Attainment in Multiple Sclerosis: A Preliminary Study.
心理社会因素与多发性硬化症患者步行相关目标的达成有关:一项初步研究。
Int J MS Care. 2025 Feb 24;27(Q1):56-62. doi: 10.7224/1537-2073.2024-045. eCollection 2025 Jan.
4
Post-acute sequela of COVID-19 infection in individuals with multiple sclerosis.患有多发性硬化症的个体感染新冠病毒后的急性后遗症。
Mult Scler. 2025 Mar;31(3):314-323. doi: 10.1177/13524585241310104. Epub 2025 Jan 3.
5
Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple Sclerosis.新型冠状病毒肺炎感染对多发性硬化症症状严重程度及残疾状况的影响
Neurology. 2025 Jan 28;104(2):e210149. doi: 10.1212/WNL.0000000000210149. Epub 2024 Dec 23.
6
Patient-reported disability progression outcomes among patients with multiple sclerosis: Results of an outcomes-based agreement.多发性硬化症患者报告的残疾进展结局:基于结局的协议的结果。
J Manag Care Spec Pharm. 2024 Nov;30(11):1211-1216. doi: 10.18553/jmcp.2024.30.11.1211.
7
Multiple sclerosis subgroups: Data-driven clusters based on patient-reported outcomes and a large clinical sample.多发性硬化亚组:基于患者报告结局和大样本临床数据的驱动聚类。
Mult Scler. 2024 Nov;30(13):1642-1652. doi: 10.1177/13524585241282763. Epub 2024 Oct 17.
8
Mobility trajectories in multiple sclerosis: A comparative study of timed 25-foot walk and a patient-reported outcome measure.多发性硬化症中的移动轨迹:计时 25 英尺步行和患者报告结局测量的比较研究。
Mult Scler. 2024 Oct;30(11-12):1479-1489. doi: 10.1177/13524585241274607. Epub 2024 Sep 5.
9
Perceived physical and mental fatigability in older adults with and without multiple sclerosis.老年人多发性硬化症患者与非患者的感知身体和精神疲劳。
Mult Scler Relat Disord. 2024 Oct;90:105807. doi: 10.1016/j.msard.2024.105807. Epub 2024 Aug 6.
10
Best practice exercise for emerging depression in multiple sclerosis: A systematic review and meta-analysis.多发性硬化症中早期抑郁的最佳实践练习:系统评价和荟萃分析。
Clin Rehabil. 2024 Sep;38(9):1171-1187. doi: 10.1177/02692155241262884. Epub 2024 Jul 25.